N
PROK icon

Nuveen’s ProKidney PROK Stock Holding History

Nuveen’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-266,366
Closed -$233K – 3377
2025
Q1 		$233K Hold
266,366
– – ﹤0.01% 3091
2024
Q4 		$450K Buy
266,366
+39,216
+17% +$70.7K ﹤0.01% 3018
2024
Q3 		$436K Sell
227,150
-60,879
-21% -$138K ﹤0.01% 3054
2024
Q2 		$709K Buy
288,029
+152,199
+112% +$409K ﹤0.01% 2872
2024
Q1 		$223K Hold
135,830
– – ﹤0.01% 3164
2023
Q4 		$242K Sell
135,830
-17,330
-11% -$37.2K ﹤0.01% 3183
2023
Q3 		$701K Sell
153,160
-57,732
-27% -$553K ﹤0.01% 2719
2023
Q2 		$2.36M Buy
+210,892
New +$2.24M ﹤0.01% 2271

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nuveen's PROK Position: Q2 2025 in Review

Nuveen sold out of ProKidney (PROK) in Q2 2025, closing a stake of 266,366 shares — an estimated $233K sold.

Nuveen first reported a position in PROK in Q2 2023 and held it in 8 quarters. The position peaked at $2.36M in Q2 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Nuveen reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 266,366 ProKidney shares in Q2 2025, an estimated $233K.
  • Nuveen first reported a position in ProKidney in Q2 2023 and held it in 8 quarters.
  • Nuveen's ProKidney position peaked at $2.36M in Q2 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.